Top Sell
| Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel ▼ | Potential |
|---|---|---|---|---|---|---|---|
| Intellia Therapeutics Inc | 14 | 1 | 2 | 1 | 21,14 € | 60,13 € | 184,44 % |
| Xenon Pharmaceuticals Inc. | 1 | 1 | 0 | 0 | 35,00 € | 50,00 € | 42,86 % |
| Cytomx Therapeutics Inc | 1 | 1 | 0 | 0 | 1,53 € | 50,00 € | 3159,45 % |
| Agenus Inc. | 3 | 2 | 1 | 0 | 0,41 € | 36,85 € | 8804,78 % |
| Rocket Pharmaceuticals Inc | 2 | 1 | 1 | 0 | ? | 32,00 € | 52,31 % |
| Palisade Bio Inc. | 3 | 1 | 0 | 0 | 0,34 € | 21,06 € | 6072,33 % |
| Fate Therapeutics Inc. | 3 | 3 | 0 | 1 | 3,34 € | 8,27 € | 147,71 % |
| Karyopharm Therapeutics Inc. | 9 | 2 | 1 | 0 | 0,90 € | 7,38 € | 722,21 % |
| Trevena Inc. | 2 | 16 | 1 | 2 | 0,34 € | 6,48 € | 1800,88 % |
| Chimerix Inc. | 3 | 1 | 0 | 0 | 0,86 € | 5,51 € | 541,23 % |
| Gritstone Oncology Inc | 4 | 2 | 2 | 0 | 0,66 € | 5,07 € | 663,03 % |
| Coherus Bioscien. | 2 | 2 | 0 | 0 | 1,57 € | 3,00 € | 91,33 % |
| Atara Biotherapeutics Inc. | 2 | 3 | 0 | 0 | 0,49 € | 3,00 € | 518,56 % |
| Protalix Biotherapeutics Inc. | 1 | 2 | 0 | 0 | 1,04 € | 2,00 € | 91,66 % |
| Promis Neurosciences Inc. | 0 | 1 | 0 | 0 | 1,48 € | 1,20 € | -18,92 % |
| Medigene AG | 1 | 2 | 1 | 0 | 1,33 € | 1,00 € | -24,53 % |
| Biofrontera AG | 0 | 2 | 0 | 0 | 0,33 € | 0,000 € | -100,00 % |
| Eagle Pharmaceuticals Inc | 0 | 1 | 0 | 0 | 3,44 € | - | - |
| Salarius Pharmaceuticals Inc. | 0 | 1 | 0 | 0 | 0,34 € | - | - |
| Nymox Pharmaceutical Corp. | 0 | 2 | 0 | 0 | 0,23 € | - | - |
| Organovo Holdings Inc. | 0 | 7 | 0 | 1 | 0,87 € | - | - |
| Minerva Neurosciences Inc. | 0 | 5 | 0 | 2 | 3,00 € | - | - |
| Neptune Wellness Solutions Inc | 0 | 13 | 0 | 0 | 0,14 € | - | - |
| Synthetic Biologics Inc. | 0 | 1 | 0 | 0 | 0,23 € | - | - |
| Anavex Life Sciences Corp | 0 | 2 | 0 | 0 | 3,59 € | - | - |